kyntheum
leo pharma a/s - brodalumab - psoriasi - immunosoppressori - kyntheum è indicato per il trattamento della psoriasi a placche da moderata a severa in pazienti adulti candidati alla terapia sistemica.
adtralza
leo pharma a/s - tralokinumab - dermatite, atopica - altri preparati dermatologici - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
voriconazolo sandoz gmbh
sandoz gmbh - voriconazolo - voriconazolo
irbesartan macleods pharma
macleods pharma espana, s.l.u. - irbesartan - irbesartan
pantoprazolo macleods
macleods pharma espana, s.l.u. - pantoprazolo - pantoprazolo
levofloxacina macleods
macleods pharma uk limited - levofloxacina - levofloxacina
physiotens mite 0,2 mg compresse rivestite con film
viatris pharma gmbh - moxonidinum - compresse rivestite con film - moxonidinum 0.2 mg, lactosum monohydricum 95.8 mg, povidonum k 25, crospovidonum, magnesii stearas, Überzug: hypromellosum, ethylcellulosum, macrogolum 6000, talcum, e 171, e 172 (rubrum), pro compresso obducto. - antihypertonicum - synthetika
physiotens 0,3 mg compresse rivestite con film
viatris pharma gmbh - moxonidinum - compresse rivestite con film - moxonidinum 0.3 mg, lactosum monohydricum 95.7 mg, povidonum k 25, crospovidonum, magnesii stearas, Überzug: hypromellosum, ethylcellulosum, macrogolum 6000, talcum, e 171, e 172 (rubrum), pro compresso obducto. - antihypertonicum - synthetika
physiotens forte 0,4 mg compresse rivestite con film
viatris pharma gmbh - moxonidinum - compresse rivestite con film - moxonidinum 0.4 mg, lactosum monohydricum 95.60 mg, povidonum k 25, crospovidonum, magnesii stearas, Überzug: hypromellosum, ethylcellulosum, macrogolum 6000, talcum, e 171, e 172 (rubrum), pro compresso obducto. - antihypertonicum - synthetika
olmesartan medoxomil e amlodipina macleods
macleods pharma espana, s.l.u. - olmesartan medoxomil and amlodipine - olmesartan medoxomil and amlodipine